This website uses cookies to improve your experience. You can accept or reject analytics cookies
A Szív- És Érrendszeri Betegségek Megelőzésének És Gyógyításának Nemzeti Programja
Cardiovascular HealthNational Control Plan2006
HungaryEnglishPDF
National
AI-Generated Document Summary
Objectives
The National Programme for the Prevention and Treatment of Cardiovascular Diseases provides a long-term, integrated framework to reduce cardiovascular disease incidence, premature mortality, disability and health inequalities in Hungary, while improving healthy life expectancy, quality of care, rehabilitation and the cost-effectiveness of the health system.It addresses the exceptionally high cardiovascular burden, including mortality substantially above the European Union average and marked regional, socioeconomic, sex and age inequalities.
Reduce population cardiovascular risk through health promotion, primary prevention and healthier social norms for diet, physical activity, smoking, alcohol use and obesity.
Prevent and manage hypertension, diabetes, lipid disorders, obesity, chronic kidney disease, coronary heart disease, heart failure, stroke, peripheral vascular disease and related conditions.
Improve risk self-assessment, screening, early diagnosis, preventive treatment and the identification of people at high cardiovascular risk.
Strengthen treatment, emergency response, rehabilitation, continuing care and home-based support so that patients receive equitable, high-quality care across the country.
Increase healthy life expectancy by three years for women and men, reduce the prevalence of people at high cardiovascular risk by 5%, and reduce preventable mortality, organ damage, disability and lost life-years.
Develop modern diagnostic and therapeutic capacity, European-standard professional training, teleconsultation and integrated patient information systems.
Align cardiovascular action with the National Public Health Programme, national development and spatial-development strategies, and related programmes on nutrition, physical activity, smoking cessation, maternity care, emergency care and rehabilitation.
Implementation
Implementation combines population health promotion, risk-based prevention, coordinated primary and specialist care, regional service planning, evidence-based clinical guidance and cross-sectoral participation.The programme envisages a unified network of Vascular and Cardiovascular Centres connected with primary care, emergency services, regional institutions, rehabilitation providers and epidemiological networks.Governance is to involve a National Programme Council, professional bodies, public-health institutions, government, local authorities, civil society, schools, workplaces and healthcare professionals.
Establish a Programme Council comprising social, professional and civil representatives, ministries and national authorities to develop sub-programmes, assign responsibilities and deadlines, monitor implementation and propose amendments.
Strengthen primary care as the entry point for health promotion, prevention, cardiovascular risk assessment, treatment follow-up, health education and epidemiological data collection.
Develop small-area community centres, Regional Primary Care Centres and health-promotion centres linked to local government and the National Public Health and Medical Officer Service.
Establish Vascular Centres with defined staff, infrastructure and specialist capacity, connecting cardiology, neurology, angiology and vascular surgery, nephrology, metabolic medicine, obstetrics, emergency care and primary care.
Coordinate regional institutional centres, universities and leading hospitals as higher levels of care, including invasive cardiology, intensive stroke and metabolic care, acute renal-failure care and heart transplantation where quality-assurance conditions are met.
Expand rehabilitation centres, home care, specialist home nursing, disability support, social-care facilities and opportunities for physical activity and return to family, community and employment.
Deliver public education through schools, school health and health visitor services, occupational health, the Hungarian Red Cross, civil organisations, peer educators, media and information providers.
Promote routine cardiovascular risk assessment during clinical consultations and population, school and occupational-health screening, using Hungarian therapeutic consensus guidance and risk-assessment tools.
Develop emergency-care capacity covering alerting, information technology, pre-hospital care, hospital diagnostics and treatment, alongside public education in first aid and basic resuscitation.
Introduce perinatal prevention measures, including a premature-birth prevention programme, strengthened Regional Perinatal Intensive Centres, pre-pregnancy assessment and counselling, and an online birth-notification system.
Build interoperable data systems, including a shared patient database, electronic medical records or health card, electronic forms and online links between providers to support patient-pathway tracking and clinical reporting.
Use European Union-comparable indicators, including European Community Health Indicators and relevant cardiovascular and diabetes indicator frameworks, supported by unified risk, epidemiological and service data collection.
Publish programme indicators, conduct population surveys and patient-satisfaction studies, supervise quality with the National Centre for Professional Supervision and Methodology, and identify patient-safety risks requiring preventive action.
Track cardiovascular frequency, mortality, medically preventable mortality, risk-factor prevalence, life expectancy, quality-adjusted life-years, treatment coverage, rehabilitation outcomes and health equity.
Use a national website, telecommunications and coordination office, electronic and print materials, and ongoing communication of results to professionals and the public.
Provide personnel, infrastructure, specialist services and information technology for the proposed network, although no programme budget, funding allocation, financing mechanism or quantified resource gap is specified.
Monitoring & Evaluation
The National Programme combines population surveillance, clinical risk assessment, service-quality monitoring and programme oversight, but its monitoring architecture is unevenly specified across components. It envisages unified data management, European-comparable indicators, epidemiological networks, electronic records and public reporting, while many extracts do not define reporting cycles, evaluation methods or independent accountability arrangements.
Monitor cardiovascular disease frequency, mortality, premature mortality, morbidity, disability, lost life-years, life expectancy, health equity, quality of life and quality-adjusted life-years.
Track behavioural and metabolic risks, including smoking, alcohol consumption, obesity, physical inactivity, hypertension, diabetes, lipid disorders and other cardiovascular risk factors.
Measure preventable mortality, organ damage, myocardial infarction, stroke, the proportion of identified and appropriately treated patients, rehabilitation outcomes and the prevalence of people at high cardiovascular risk.
Assess population cardiovascular health to quantify risks and establish national target values, including through a Hungarian SCORE risk-assessment system and a cardiovascular risk data-collection system.
Apply the examinations and target values of the II Hungarian Therapeutic Consensus Conference to screening, risk assessment and intervention guidance.
European Community Health Indicators are proposed as the preferred basis for internationally comparable monitoring, including cardiovascular indicators developed through EUROCISS and diabetes indicators developed through EUDIP. The indicator scope is intended to cover health status; demographic and socioeconomic determinants; biological and behavioural risks; healthcare; and health-promotion interventions.
Create a unified database for risk assessment, epidemiological information and indicator collection across professional areas.
Use electronic forms, electronic medical records and a health card to support information management.
Link cardiovascular risk data collection to the epidemiological network’s data-collection and evaluation system.
Capture screening participation, healthy-lifestyle programme participation, patient-management information and risk factors through the proposed electronic health card or record, subject to information-technology and legal changes.
Use epidemiological assessment centres to assess health status, morbidity and mortality and to inform professional and health-policy strategy.
The programme also proposes common monitoring, evaluation, inspection and quality-assurance systems for prevention, early detection, treatment and rehabilitation. Organisational guidance, professional guidelines, protocols and indicators are to be developed for participating professions and institutions, with the National Centre for Professional Supervision and Methodology supporting supervision and quality inspection.
Develop and publish a cardiovascular programme indicator system and indicators associated with relevant clinical guidelines and protocols.
Conduct population surveys and patient-satisfaction studies to monitor health-promotion and patient-care results.
Identify patient-safety risks associated with activities and interventions and prepare preventive safety measures.
Monitor implementation through the National Programme Council and propose programme modifications where necessary.
Assign quality assurance to participating teachers, civil-society organisations, primary-care and public-health staff, school and occupational health services, and the health visitor network.
Specified implementation milestones include preparation of organisational guidance by September 2006, development of professional guidelines and protocols from November 2006 onwards, publication of monitoring indicators by October 2006, and continuous population and patient-satisfaction monitoring from January 2007.A national programme website was planned from 1 January 2007 to communicate current results to professionals and the public.
Clinical monitoring includes maintaining blood pressure below 140/90 millimetres of mercury among healthy people and increasing the proportion of treated patients below this threshold to more than 50%.An ankle-brachial index below 0.9 is a trigger for further angiological assessment and cardiovascular risk evaluation, while a glomerular filtration rate below 60 millilitres per minute identifies patients requiring joint nephrology and primary-care management.
Evidence reviewed by the programme supports repeated surveillance of disease occurrence, mortality, medical care and risk-factor trends. The World Health Organization MONICA Project monitored these domains internationally, and community interventions were assessed through baseline, end-of-programme and follow-up comparisons of knowledge, risk factors and health status.However, several sections do not specify detailed indicator definitions, reporting formats, reporting schedules, evaluation responsibilities, surveillance procedures or independent accountability mechanisms.
Costing & Financing
The programme identifies resource needs and a commitment to cost-effective care, but provides no quantified programme budget, cost estimates, funding allocations, funding gap or economic assumptions.
Moderate the unavoidable growth in health expenditure through sustainable health-system development.
Address relatively limited health resources and the territorial inequalities reinforced by existing expenditure and investment patterns.
Support a sector-neutral financing system founded on solidarity and equal opportunities.
Provide resources for Vascular Centre personnel, infrastructure, specialist services, information technology and, where quality-assurance conditions require it, a second Hungarian heart-transplant centre.
Invest in service restructuring, emergency, chronic-care and rehabilitation capacity, accessibility, digital health, research and innovation, without specified financial values.
Adjust the health budget to enable access to new preventive treatments for people at risk, while recognising the financial consequences of inaction.
Cost-effectiveness is an explicit programme objective alongside improved quality, equity and accessibility of services, and the programme calls for cost-effective, evidence-based community prevention initiatives.The source does not identify financing sources, budget holders, resource-mobilisation mechanisms, unit costs or the division of financial responsibility between institutions.